Advisor Group Holdings Inc. boosted its position in Axon Enterprise, Inc. (NASDAQ:AXON – Get Rating) by 10.3% in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 19,847 shares of the biotechnology company's stock after purchasing an additional 1,858 shares during the quarter. Advisor Group Holdings Inc.'s holdings in Axon Enterprise were worth $2,693,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors have also recently added to or reduced their stakes in the company. Washington Harbour Partners LP acquired a new position in Axon Enterprise in the 4th quarter valued at about $2,098,000. Teacher Retirement System of Texas raised its stake in Axon Enterprise by 17.8% in the 4th quarter. Teacher Retirement System of Texas now owns 12,531 shares of the biotechnology company's stock valued at $1,967,000 after purchasing an additional 1,890 shares during the last quarter. Psagot Value Holdings Ltd. Israel acquired a new position in Axon Enterprise in the 4th quarter valued at about $63,000. Capital Fund Management S.A. raised its stake in Axon Enterprise by 25.1% in the 4th quarter. Capital Fund Management S.A. now owns 31,976 shares of the biotechnology company's stock valued at $5,020,000 after purchasing an additional 6,415 shares during the last quarter. Finally, Stephens Inc. AR raised its stake in Axon Enterprise by 23.2% in the 4th quarter. Stephens Inc. AR now owns 3,528 shares of the biotechnology company's stock valued at $554,000 after purchasing an additional 665 shares during the last quarter. Institutional investors and hedge funds own 72.06% of the company's stock.

Wall Street Analyst Weigh In

A number of research analysts have recently commented on AXON shares. Northland Securities dropped their price objective on shares of Axon Enterprise from $180.00 to $130.00 in a research note on Thursday, May 12th. StockNews.com raised shares of Axon Enterprise from a "hold" rating to a "buy" rating in a research note on Saturday, June 18th. Morgan Stanley downgraded shares of Axon Enterprise from an "overweight" rating to an "equal weight" rating and set a $120.00 price objective for the company. in a research note on Monday, May 23rd. JMP Securities reaffirmed a "buy" rating and set a $195.00 price objective on shares of Axon Enterprise in a research note on Wednesday, June 1st. Finally, Credit Suisse Group upped their price objective on shares of Axon Enterprise from $134.00 to $142.00 and gave the company an "outperform" rating in a research note on Wednesday. One equities research analyst has rated the stock with a hold rating and eight have given a buy rating to the company. According to MarketBeat, Axon Enterprise currently has a consensus rating of "Moderate Buy" and an average target price of $163.25.

Axon Enterprise Stock Up 4.3 %

Axon Enterprise (NASDAQ:AXON – Get Rating) last released its quarterly earnings results on Tuesday, August 9th. The biotechnology company reported $0.44 earnings per share for the quarter, topping analysts' consensus estimates of $0.39 by $0.05. The firm had revenue of $285.61 million during the quarter, compared to analysts' expectations of $258.96 million. Axon Enterprise had a return on equity of 12.57% and a net margin of 14.20%. Axon Enterprise's quarterly revenue was up 30.5% compared to the same quarter last year. During the same quarter in the prior year, the business earned ($0.72) EPS. Sell-side analysts expect that Axon Enterprise, Inc. will post 1.46 earnings per share for the current year.

Insiders Place Their Bets

In other Axon Enterprise news, Director Mark W. Kroll sold 3,159 shares of the company's stock in a transaction that occurred on Wednesday, June 8th. The stock was sold at an average price of $102.82, for a total value of $324,808.38. Following the completion of the transaction, the director now owns 13,691 shares in the company, valued at approximately $1,407,708.62. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 6.90% of the stock is owned by company insiders.

About Axon Enterprise

(Get Rating)

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, TASER, and Software and Sensors. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.

Featured Stories

• Get a free copy of the StockNews.com research report on Axon Enterprise (AXON)
• 2 Important Retail Stock Battles to Watch
• MarketBeat: Week in Review 8/8 – 8/12
• What Is WallStreetBets and What Stocks Are They Targeting?
• Institutions And Analysts Propel Jack In The Box Higher
• Can You Guess Which EV Stock Is Beating Tesla ?

Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc. (NASDAQ:AXON – Get Rating).

Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.